These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 690848)

  • 1. Comparison of in vitro dissolution and in vivo bioavailability of methaqualone tablets in humans.
    Stoll RG; Chao GC; Hoyt HJ; Yacobi A
    J Pharm Sci; 1978 Sep; 67(9):1328-9. PubMed ID: 690848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between dissolution characteristics and absorption of methaqualone from solid dosage forms.
    Chemburkar PB; Smyth RD; Buehler JD; Shah PB; Joslin RS; Polk A; Reavey-Cantwell NH
    J Pharm Sci; 1976 Apr; 65(4):529-33. PubMed ID: 1271252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men.
    Waller ES; Crismon ML; Smith RV; Bauza MT; Doluisio JT
    Biopharm Drug Dispos; 1988; 9(2):211-8. PubMed ID: 3370308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability of josamycin, a macrolide antibiotic, from a tablet and solution and the influence of dissolution on in vivo release.
    Skinner M; Kanfer I
    Biopharm Drug Dispos; 1998 Jan; 19(1):21-9. PubMed ID: 9510982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution systems for chloramphenicol tablet bioavailability.
    Ogata H; Shibazaki T; Inoue T; Ejima A
    J Pharm Sci; 1979 Jun; 68(6):712-5. PubMed ID: 37318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between in vitro dissolution rate and bioavailability of alaproclate tablets.
    Graffner C; Nicklasson M; Lindgren JE
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):367-80. PubMed ID: 6527230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bioinequivalence of carbamazepine tablets with a history of clinical failures.
    Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Pelsor FR; Shah VP
    Pharm Res; 1992 Dec; 9(12):1612-6. PubMed ID: 1488405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.
    Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tsuji S; Kawazu Y
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro-in vivo correlation of modified release dosage form of lamotrigine.
    Shah HJ; Subbaiah G; Patel DM; Patel CN
    Biopharm Drug Dispos; 2009 Dec; 30(9):524-31. PubMed ID: 19823969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations, bioavailability and dissolution of chlorpropamide.
    Taylor T; Assinder DF; Chasseaud LF; Bradford PM; Burton JS
    Eur J Clin Pharmacol; 1977 Mar; 11(3):207-212. PubMed ID: 15845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazides IV: Comparison of dissolution with bioavailability of chlorothiazide tablets.
    Shah VP; Knight P; Prasad VK; Cabana BE
    J Pharm Sci; 1982 Jul; 71(7):822-4. PubMed ID: 7120073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between dissolution rate and bioavailability of paracetamol tablet.
    Huang XP; Wan XX; Liu Q
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):367-8, 371. PubMed ID: 12697478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.
    Helmy SA; El Bedaiwy HM
    Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.